We are thrilled to announce that knowing01 has successfully raised $20 million in our latest funding round, a significant step towards revolutionizing the landscape of early-phase drug discovery. Our mission is clear: to reshape how data is utilized in the quest to address todayโs unmet medical needs with improved certainty. Central to our innovative approach is our cutting-edge software solution, which contextualizes Multiomics data while effectively mitigating risks associated with critical decisions concerning targets and diseases.
At knowing01, we recognize that a staggering 80% of data context is often overlooked, which is why our technology is designed to harness Multiomics data like never before. Our unique Cellmap technology remains unmatched, offering incredible flexibility across various biological data types. By streamlining research and uncovering vital insights, we are dedicated to advancing therapeutic strategies that can profoundly change lives.
This funding will enable us to enhance our proprietary knowledge graphs and further develop our machine learning and artificial intelligence capabilities, ultimately strengthening our position as a strategic partner in the data-to-outcome process. Collaborating closely with our founding team's deep expertise in research and commercial experience, we are poised to unlock both private and public data, breaking down traditional barriers and accelerating outcomes in drug discovery.
At knowing01, we firmly believe that better research leads to better health. We invite you to follow us on our exciting journey as we tackle tomorrow's medical challenges together. Join us in shaping the future of healthcare.
